PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, among many more.
| Industry: | Health Care |
| Sector: | Health Care |
| Website: | puretechhealth.com |
| Exchange: | LSE |
| Admission date: | 18 Jun 2015 |
| Market: | Main Market |
| Region: | Europe |
| 29 Aug 2023 | Half-year Report |
| 28 Apr 2023 | PRTC Final Results & Publication of Annual Report |
| 25 Aug 2022 | Half-year Report |
| 26 Apr 2022 | PRTC Final Results & Publication of Annual Report |
| 13 Jun 2023 | Annual General Meeting |
| 28 Apr 2023 | Presentation and Conference Call |
| 28 Apr 2023 | Webcast and Conference Call |
| 20 Mar 2023 | Conference Call and Webcast |
| 26 Apr 2022 | Presentation and Conference Call |